Capricor Therapeutics, Inc. News: Capricor Therapeutics Announces Intent to File Biologics License Application for Full Approval of Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy
Recent NewsView All News
Recent Events View All Events
29th Annual Congress of the World Muscle Society (WMS 2024)
Latest Presentation View All Presentations
Email Alerts
Sign up for email alerts for Press Releases & SEC Filings